Vanderbilt-Ancora Partnership Advances Research for Charcot-Marie-Tooth Disease
November 18, 2020
November 18, 2020
NASHVILLE, Tennessee, Nov. 18 (TNSRes) -- Vanderbilt University issued the following news:
Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt University's innovative life science research, will fund further research into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves. This is the third Vanderbilt project Ancora has funded.
Charles Sanders, associate dean for research and professor of . . .
Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt University's innovative life science research, will fund further research into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves. This is the third Vanderbilt project Ancora has funded.
Charles Sanders, associate dean for research and professor of . . .